LENZ
Companies
NASDAQ
Lenz Therapeutics Inc.
Health Care
$29.83
+$0.96 (+3.33%)
Price Chart
Overview
About LENZ
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Market Cap
$397.8M
Volume
7.1M
Avg. Volume
7.4M
P/E Ratio
-7.953192
Dividend Yield
0.00%
Employees
119.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.96
Moderate Correlation
Volatility
High (0.84)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, LENZ shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025